Staying Ahead: Long-Term Monitoring and Health Checks

Because Familial Partial Lipodystrophy Type 5 (FPLD5) is a progressive condition, long-term health depends on consistent, proactive monitoring. The goal of “surveillance” is to catch metabolic shifts early, before they cause permanent damage to your organs ^[1]. International guidelines, such as those from the Endocrine Society, recommend a multidisciplinary approach to track how the lack of healthy fat storage affects your entire body ^[1][2].

The Annual Check-Up: A Specialized Roadmap

At a minimum, you should have a comprehensive metabolic evaluation once a year ^[1]. If your lab results are unstable or your triglycerides are very high, your doctor may require testing every 3 to 6 months. A standard annual surveillance schedule includes:

• Metabolic Panel: Tracking HbA1c, fasting lipids (triglycerides and cholesterol), and fasting glucose ^[1].
• Liver Assessment: Blood tests for liver enzymes (ALT and AST) and imaging to check for fat accumulation (steatosis) ^[2][1].
• Kidney Screen: A urine test to look for albuminuria (protein in the urine), which is an early sign of kidney stress ^[1][3].
• Cardiovascular Check: Monitoring blood pressure and assessing your overall risk for heart disease or atherosclerosis (narrowing of the arteries) ^[1][4].

However, there is no single universal interval for liver imaging, FibroScan, or advanced cardiac imaging; frequency should depend on your specific diabetes control, triglycerides, and symptoms. Patients with diabetes also need ordinary surveillance such as estimated glomerular filtration rate (eGFR), retinal examinations, and foot/neuropathy assessments.

Why “Fasting” Isn’t Always Enough

In many standard medical exams, doctors only check fasting glucose (blood sugar after not eating). However, in FPLD, this number can be misleadingly normal even when your body is struggling to manage sugar ^[5].

An Oral Glucose Tolerance Test (OGTT) can be useful when fasting glucose and HbA1c are discordant, or if clinical suspicion remains high ^[5]. In this test, you drink a sugary liquid, and your blood sugar is measured two hours later. In one study of adults with FPLD2, 86% of those with prediabetes had a perfectly normal fasting glucose but showed significant issues during the OGTT ^[5]. Identifying these “early alterations” allows for earlier intervention with diet or medication ^[5][6].

Protecting Your Vital Organs

• The Liver: Because fat that cannot be stored under the skin often ends up in the liver, monitoring for Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) is essential ^[1]. Your doctor may use transient elastography (often called a FibroScan) to measure liver stiffness and check for signs of scarring or fibrosis ^[7], while a steatosis estimate is a separate measurement.
• The Kidneys: High levels of insulin and lipids can place a heavy burden on the kidneys. Long-term follow-up is necessary because some patients with FPLD may develop progressive protein loss in their urine, which can lead to decreased kidney function if not managed ^[3][8].
• The Heart: People with FPLD have a higher risk for early heart disease. Monitoring includes regular blood pressure checks and, in some cases, specialized heart imaging or ECGs to ensure the heart muscle and rhythm remain healthy ^[2][4].

Reproductive Health and Pregnancy

For women with FPLD5, high insulin levels can disrupt reproductive hormones, leading to Polycystic Ovary Syndrome (PCOS) and hirsutism (excess hair growth) ^[9][2].

If you are planning a pregnancy, it is vital to coordinate with your metabolic specialist early. Pregnancy in FPLD requires intensive monitoring, as the natural changes in hormones can cause triglycerides to skyrocket, increasing the risk of gestational diabetes or pancreatitis ^[10][11]. Many commonly used agents, including GLP-1 agonists, SGLT2 inhibitors, statins, fibrates, renin–angiotensin system blockers, and metreleptin, may require stopping, substitution, or a specialist risk–benefit discussion before conception. Estrogen-containing contraception is not automatically prohibited but may be unsuitable when triglycerides are substantially elevated ^[12].